TNFRSF18 and autoimmune disease: GITR+ Tregs are markedly lower in frequency in autoimmune diseases including type 1 diabetes and systemic lupus erythematous, and increasing the frequency of GITR+ Tregs is associated with the remission in these conditions [56–59].